Scholarlink

Background and Objective <p>Fixed-dose combinations (FDCs) of amlodipine and telmisartan are widely used for hypertension management owing to their efficacy and improved adherence. This study aimed to characterize the pharmacokinetics (PKs) of both drugs after a single oral dose of a single-pill FDC of amlodipine 5 mg/telmisartan 80 mg in healthy Korean males.</p> Methods <p>A total of 681 amlodipine and 1500 telmisartan plasma concentrations from 32 healthy Korean males were retrospectively obtained from a bioequivalence study. Noncompartmental analysis and population analysis were conducted using WinNonLin™ (Pharsight Corp., Mountain View, CA, USA) and NONMEM<sup>®</sup> (ICON Development Solutions, Hanover, MD, USA), respectively. A two-compartment model with first-order absorption and elimination was selected for both drugs. Covariate screening using a stepwise approach evaluated 38 demographic and clinical factors.</p> Results <p>Amlodipine exhibited a longer half-life and a larger apparent volume of distribution than telmisartan. Telmisartan PKs showed high interindividual (45.9% for absorption rate constant, 45.3% for apparent volume of distribution of the central compartment [<i>V</i><sub>1</sub>/<i>F</i>], and 40.9% for apparent clearance [CL/<i>F</i>]), interoccasion (53.7% for <i>V</i><sub>1</sub>/<i>F</i>), and residual (80.3%) variabilities. Preliminary covariate analysis suggested that body surface area and age potentially influenced <i>V</i><sub>1</sub>/<i>F</i> and CL/<i>F</i> for amlodipine, while height, smoking status, and total bilirubin levels were associated with telmisartan <i>V</i><sub>1</sub>/<i>F</i> and CL/<i>F</i>.</p> Conclusions <p>To our knowledge, this is the first population PK study to characterize the PKs of amlodipine and telmisartan co-administered as a single-pill FDC and to identify preliminary covariates that may influence their PK profiles.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Population Pharmacokinetics of Amlodipine and Telmisartan Following Oral Administration of a Single-Pill Fixed-Dose Combination in Healthy Korean Male Subjects

  • 期刊论文

  • 发表日期：

    2025年12月23日

查看全文
  • Eunji Yu,
  • Hee Kyung Hwang,
  • Bo Ram Kim,
  • Hyo Cheol Kim,
  • Seh Hyon Song,
  • Woojin Jung,
  • Christine E. Staatz,
  • Min-Soo Kim,
  • In-hwan Baek

摘要

Background and Objective

Fixed-dose combinations (FDCs) of amlodipine and telmisartan are widely used for hypertension management owing to their efficacy and improved adherence. This study aimed to characterize the pharmacokinetics (PKs) of both drugs after a single oral dose of a single-pill FDC of amlodipine 5 mg/telmisartan 80 mg in healthy Korean males.

Methods

A total of 681 amlodipine and 1500 telmisartan plasma concentrations from 32 healthy Korean males were retrospectively obtained from a bioequivalence study. Noncompartmental analysis and population analysis were conducted using WinNonLin™ (Pharsight Corp., Mountain View, CA, USA) and NONMEM® (ICON Development Solutions, Hanover, MD, USA), respectively. A two-compartment model with first-order absorption and elimination was selected for both drugs. Covariate screening using a stepwise approach evaluated 38 demographic and clinical factors.

Results

Amlodipine exhibited a longer half-life and a larger apparent volume of distribution than telmisartan. Telmisartan PKs showed high interindividual (45.9% for absorption rate constant, 45.3% for apparent volume of distribution of the central compartment [V1/F], and 40.9% for apparent clearance [CL/F]), interoccasion (53.7% for V1/F), and residual (80.3%) variabilities. Preliminary covariate analysis suggested that body surface area and age potentially influenced V1/F and CL/F for amlodipine, while height, smoking status, and total bilirubin levels were associated with telmisartan V1/F and CL/F.

Conclusions

To our knowledge, this is the first population PK study to characterize the PKs of amlodipine and telmisartan co-administered as a single-pill FDC and to identify preliminary covariates that may influence their PK profiles.